Century Therapeutics

$17.20 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Century Therapeutics

Century Therapeutics, Inc. operates as a biotech company. The Company specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services. Century Therapeutics serves customers worldwide.

Stock Analysis

last close $17.2
1-mo return -18%
3-mo return -26.2%
avg daily vol. 80.32T
52-week high 32.9
52-week low 16.29
market cap. $1.1B
forward pe -
annual div. -
roe -
ltg forecast -17.2%
dividend yield -
annual rev. $--
inst own. 41.8%
baraka

Subscribe now for daily local and international financial news

Subscribe